Company Filing History:
1 out of 1,743 
1 out of 11 
1 out of 31 
Years Active: 2022
Title: Romuald Mentaverri: Innovator in Cardiovascular Treatment
Introduction
Romuald Mentaverri is a notable inventor based in Amiens, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular conditions. His innovative work focuses on the regulation of cardiovascular calcification, a critical area in medical research.
Latest Patents
Romuald Mentaverri holds a patent for "Pharmaceutical compositions for use in the treatment of cardiovascular calcification." This patent demonstrates that the phosphatase and hydrolase domains of soluble epoxide hydrolase (sEH) play a crucial role in regulating the cardiovascular calcification process. The invention reveals that inhibiting the phosphatase domain of sEH could serve as a new pharmacological target for preventing cardiovascular calcification. The patent outlines a method for treating cardiovascular calcification using a therapeutically effective amount of an inhibitor of phosphatase activity of soluble epoxide hydrolase.
Career Highlights
Throughout his career, Romuald Mentaverri has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Rouen Normandie. His research has contributed to advancements in understanding cardiovascular diseases and potential treatment options.
Collaborations
Romuald has collaborated with notable colleagues, including Jeremy Bellien and Isabelle Six. These partnerships have enhanced his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Romuald Mentaverri's work in the pharmaceutical industry highlights his commitment to advancing treatments for cardiovascular conditions. His innovative patent and collaborations with esteemed institutions and colleagues underscore his significant impact on medical research.